Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
Steven W PipeCedric HermansMeera ChitlurManuel D CarcaoGiancarlo CastamanJoanna A DavisJonathan DucoreAmy L DunnMiguel A EscobarJanna JourneycakeOsman KhanJohnny N MahlanguShannon L MeeksIsmail Haroon MithaClaude NégrierUlrike Nowak-GöttlMichael RechtTammuella Chrisentery-SingletonOleksandra StasyshynKateryna V VilchevskaLaura Villarreal MartinezMichael WangJerzy WindygaGuy Aaron YoungW Allan AlexanderDaniel BonzoChristopher MacieIan S MitchellEvelyne SautyThomas A WilkinsonAmy D ShapiroPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Both 75 and 225 μg/kg eptacog beta IDRs provided safe and effective treatment and control of bleeding in children <12 years of age.